WAYNE, Pa., Feb. 4, 2014
/PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential
claims against the board of directors of ArthroCare Corporation
("ArthroCare" or the "Company") (NASDAQ: ARTC) concerning possible
breaches of fiduciary duty and other violations of law related to
the Company's efforts to sell the Company to Smith & Nephew
Plc. in a deal valued at approximately $1.7
billion.
(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
)
If you own shares of ArthroCare and would like to learn more
about these claims or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/artc. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the proposed transaction, ArthroCare's
stockholders will receive $48.25 for
each share of ArthroCare common stock they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by ArthroCare's Board of
Directors for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT:
|
Ryan &
Maniskas, LLP
|
|
Richard A.
Maniskas, Esquire
|
|
995 Old Eagle
School Rd., Suite 311
|
|
Wayne, PA
19087
|
|
877-316-3218
|
|
www.rmclasslaw.com/cases/artc
|
|
rmaniskas@rmclasslaw.com
|
SOURCE Ryan & Maniskas, LLP